Let’s start up with the current stock price of Adamis Pharmaceuticals Corporation (ADMP), which is $1.35 to be very precise. The Stock rose vividly during the last session to $1.5719 after opening rate of $1.54 while the lowest price it went was recorded $1.32 before closing at $1.38.
Recently in News on February 22, 2021, Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19. Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) (“Company”) announced today that the U.S. Food and Drug Administration (“FDA”) has completed the safety review of the Company’s Investigational New Drug (“IND”) application and has concluded that Adamis may proceed with the proposed clinical investigation of Tempol for the treatment of COVID-19. The clearance to proceed follows the submission of an IND application to FDA and a Pre-IND meeting. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Adamis Pharmaceuticals Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3400 on 01/22/21, with the lowest value was $0.4861 for the same time period, recorded on 01/04/21.
Adamis Pharmaceuticals Corporation (ADMP) full year performance was 112.70%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adamis Pharmaceuticals Corporation shares are logging -42.31% during the 52-week period from high price, and 400.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.27 and $2.34.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 17371108 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adamis Pharmaceuticals Corporation (ADMP) recorded performance in the market was 178.29%, having the revenues showcasing 235.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 177.26M, as it employees total of 131 workers.
The Analysts eye on Adamis Pharmaceuticals Corporation (ADMP)
During the last month, 0 analysts gave the Adamis Pharmaceuticals Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8241, with a change in the price was noted +0.5715. In a similar fashion, Adamis Pharmaceuticals Corporation posted a movement of +73.41% for the period of last 100 days, recording 13,808,027 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADMP is recording 0.19 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.05.
Technical rundown of Adamis Pharmaceuticals Corporation (ADMP)
Raw Stochastic average of Adamis Pharmaceuticals Corporation in the period of last 50 days is set at 47.06%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 41.56%. In the last 20 days, the company’s Stochastic %K was 30.90% and its Stochastic %D was recorded 32.75%.
Considering, the past performance of Adamis Pharmaceuticals Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 178.29%. Additionally, trading for the stock in the period of the last six months notably improved by 50.10%, alongside a boost of 112.70% for the period of the last 12 months. The shares increased approximately by -12.90% in the 7-day charts and went down by 6.30% in the period of the last 30 days. Common stock shares were driven by 235.24% during last recorded quarter.